ARHGAP21 Acts as an Inhibitor of the Glucose-Stimulated Insulin Secretion Process
ARHGAP21 is a RhoGAP protein implicated in the modulation of insulin secretion and energy metabolism. ARHGAP21 transient-inhibition increase glucose-stimulated insulin secretion (GSIS) in neonatal islets; however, ARHGAP21 heterozygote mice have a reduced insulin secretion. These discrepancies are n...
Main Authors: | Sandra M. Ferreira, José M. Costa-Júnior, Mirian A. Kurauti, Nayara C. Leite, Fernanda Ortis, Luiz F. Rezende, Helena C. Barbosa, Antonio C. Boschero, Gustavo J. Santos |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2020.599165/full |
Similar Items
-
Dietary Genistein Rescues Reduced Basal Chloride Secretion in Diabetic Jejunum via Sex-Dependent Mechanisms
by: Shawn Catmull, et al.
Published: (2016-11-01) -
Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in ob/ob mice
by: Kuwahara, Satoko
Published: (2017) -
Genistein treatment increases bone mass in obese, hyperglycemic mice
by: Michelin RM, et al.
Published: (2016-03-01) -
Leptin-deficient mice have altered three-dimensional growth plate histomorphometry
by: Jun Hung, et al.
Published: (2019-01-01) -
Genistein diet improves body weight, serum glucose and triglyceride levels in both male and female ob/ob mice
by: Rockwood S, et al.
Published: (2019-10-01)